×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
[V1-S5] Commercialization of Regenerative Medical Products and Quality Assurance
Session Chair(s)
Teruo Okano, PhD
Professor, Institute of Advanced BioMedical Engineering and Science
Tokyo Women's Medical University, Japan
Akihiro Umezawa, MD, PhD
Deputy Director
National Center for Child Health and Development, Japan
Speaker(s)
Japanese Regulations for Quality and Safety of Regenerative Medicine and Cell Therapy
Yoji Sato, PhD
National Institute of Health Sciences, Japan
Head, Division of Drugs
Quality control of cell processed product from autologous somatic cells
Toshiyuki Owaki, PhD
Tokyo Women's Medical University, Japan
Associate Professor, Institute of Advanced Biomedical Engineering & Science
Challenge to quality control of autologous cell products for regenerative medicine through experience from JACE? and JACC?
Kenichiro Hata, MD, PhD
Japan Tissue Engineering Co., Ltd., Japan
President and CEO,
Have an account?